These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10644353

  • 21. Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy.
    Tao Q, Yang J, Huang H, Swinnen LJ, Ambinder RF.
    Am J Pathol; 2002 May; 160(5):1839-45. PubMed ID: 12000735
    [Abstract] [Full Text] [Related]

  • 22. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 23. Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus.
    Apolloni A, Moss D, Stumm R, Burrows S, Suhrbier A, Misko I, Schmidt C, Sculley T.
    Eur J Immunol; 1992 Jan 01; 22(1):183-9. PubMed ID: 1370413
    [Abstract] [Full Text] [Related]

  • 24. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
    Crotzer VL, Christian RE, Brooks JM, Shabanowitz J, Settlage RE, Marto JA, White FM, Rickinson AB, Hunt DF, Engelhard VH.
    J Immunol; 2000 Jun 15; 164(12):6120-9. PubMed ID: 10843661
    [Abstract] [Full Text] [Related]

  • 25. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.
    Ito Y, Demachi-Okamura A, Ohta R, Akatsuka Y, Nishida K, Tsujimura K, Morishima Y, Takahashi T, Kuzushima K.
    J Gen Virol; 2007 Mar 15; 88(Pt 3):770-780. PubMed ID: 17325349
    [Abstract] [Full Text] [Related]

  • 26. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG.
    J Virol; 1993 Mar 15; 67(3):1572-8. PubMed ID: 7679748
    [Abstract] [Full Text] [Related]

  • 27. Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies.
    Micheletti F, Guerrini R, Formentin A, Canella A, Marastoni M, Bazzaro M, Tomatis R, Traniello S, Gavioli R.
    Eur J Immunol; 1999 Aug 15; 29(8):2579-89. PubMed ID: 10458773
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.
    Cirac A, Stützle S, Dieckmeyer M, Adhikary D, Moosmann A, Körber N, Bauer T, Witter K, Delecluse HJ, Behrends U, Mautner J.
    Cancer Immunol Immunother; 2018 Apr 15; 67(4):663-674. PubMed ID: 29374782
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG.
    Nature; 1995 Jun 22; 375(6533):685-8. PubMed ID: 7540727
    [Abstract] [Full Text] [Related]

  • 30. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E.
    Proc Natl Acad Sci U S A; 1990 Apr 22; 87(8):2906-10. PubMed ID: 2158098
    [Abstract] [Full Text] [Related]

  • 31. Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.
    Burrows JM, Burrows SR, Poulsen LM, Sculley TB, Moss DJ, Khanna R.
    J Virol; 1996 Apr 22; 70(4):2490-6. PubMed ID: 8642677
    [Abstract] [Full Text] [Related]

  • 32. Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3.
    Misko IS, Schmidt C, Moss DJ, Burrows SR, Sculley TB.
    J Gen Virol; 1991 Feb 22; 72 ( Pt 2)():405-9. PubMed ID: 1704413
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D, Destro F, Baldisserotto A, Marastoni M, Coppotelli G, Masucci M, Gavioli R.
    Immunology; 2010 Mar 22; 129(3):386-95. PubMed ID: 19922423
    [Abstract] [Full Text] [Related]

  • 35. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R, Burrows SR, Nicholls J, Poulsen LM.
    Eur J Immunol; 1998 Feb 22; 28(2):451-8. PubMed ID: 9521052
    [Abstract] [Full Text] [Related]

  • 36. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.
    Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, Khanna R.
    J Virol; 1998 Aug 22; 72(8):6614-20. PubMed ID: 9658107
    [Abstract] [Full Text] [Related]

  • 37. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS.
    Int Immunol; 1997 Nov 22; 9(11):1745-55. PubMed ID: 9418135
    [Abstract] [Full Text] [Related]

  • 38. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G, Mayrhofer S, Taylor G, Haigh T, Leese A, Rickinson A, Blake N.
    J Exp Med; 2001 Oct 15; 194(8):1053-68. PubMed ID: 11602636
    [Abstract] [Full Text] [Related]

  • 39. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.
    Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A.
    J Immunol; 2000 Dec 15; 165(12):7078-87. PubMed ID: 11120837
    [Abstract] [Full Text] [Related]

  • 40. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.
    Ito Y, Kondo E, Demachi-Okamura A, Akatsuka Y, Tsujimura K, Tanimoto M, Morishima Y, Takahashi T, Kuzushima K.
    J Virol; 2006 Jan 15; 80(2):883-90. PubMed ID: 16378990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.